These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 4098172)
1. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. Bokisch VA; Müller-Eberhard HJ J Clin Invest; 1970 Dec; 49(12):2427-36. PubMed ID: 4098172 [TBL] [Abstract][Full Text] [Related]
2. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. Bokisch VA; Müller-Eberhard HJ; Cochrane CG J Exp Med; 1969 May; 129(5):1109-30. PubMed ID: 5778786 [TBL] [Abstract][Full Text] [Related]
3. ["In vitro" protaminase activity of human plasma and serum and the human carboxypeptidase N (author's transl)]. Blass J; Verriest C; Vicaigne MB; Weiss M Pathol Biol (Paris); 1980 Oct; 28(8):527-34. PubMed ID: 6448971 [TBL] [Abstract][Full Text] [Related]
4. Human pancreatic carboxypeptidase B. I. Isolation, purification, and characterization of fraction II. Geokas MC; Largman C; Brodrick JW; Raeburn S; Rinderknecht H Biochim Biophys Acta; 1975 Jun; 391(2):396-402. PubMed ID: 807247 [TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of a new arginine carboxypeptidase in human serum. Hendriks D; Wang W; Scharpé S; Lommaert MP; van Sande M Biochim Biophys Acta; 1990 Apr; 1034(1):86-92. PubMed ID: 2328266 [TBL] [Abstract][Full Text] [Related]
6. Two distinct chemotactic factor inactivators in human serum. Till G; Ward PA J Immunol; 1975 Feb; 114(2 pt 2):843-7. PubMed ID: 46254 [TBL] [Abstract][Full Text] [Related]
7. Purification and partial characterization of human and porcine C3a anaphylatoxin. Hugli TE; Vallota EH; Müller-Eberhard HJ J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass. Kreutzer DL; McCormick JR; Despins A; Moore M; Rousou JH; Dobbs W; Engleman RN J Exp Pathol; 1984; 1(3):183-7. PubMed ID: 6336305 [TBL] [Abstract][Full Text] [Related]
9. [Effect of bradkinin-potentiating snake venom peptides and C-terminal pentapeptide fragment of bradkinin on carboxypeptidase N and kiniase activities of human blood serum]. Paskhina TS; Traleznikova SS; Egorovoa TL; Morozova NA Biokhimiia; 1975; 40(4):844-53. PubMed ID: 173428 [TBL] [Abstract][Full Text] [Related]
10. [Carboxypeptidase T--intracellular carboxypeptidase of Thermoactinomycetes--a distant analog of animal carboxypeptidase]. Osterman AL; Stepanov VM; Rudenskaia GN; Khodova OM; Tsaplina IA Biokhimiia; 1984 Feb; 49(2):292-301. PubMed ID: 6424730 [TBL] [Abstract][Full Text] [Related]
11. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. Vallota EH; Müller-Eberhard HJ J Exp Med; 1973 May; 137(5):1109-23. PubMed ID: 4121926 [TBL] [Abstract][Full Text] [Related]
12. Isolation and purification of creatine kinase conversion factor from human serum and its identification as carboxypeptidase N. Michelutti L; Falter H; Certossi S; Marcotte B; Mazzuchin A Clin Biochem; 1987 Feb; 20(1):21-9. PubMed ID: 3105932 [TBL] [Abstract][Full Text] [Related]
13. Active disassembly of the first complement component, C-1, by C-1 inactivator. Ziccardi RJ; Cooper NR J Immunol; 1979 Aug; 123(2):788-92. PubMed ID: 110880 [No Abstract] [Full Text] [Related]
14. Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N. Hendriks D; Scharpé S; van Sande M; Lommaert MP J Clin Chem Clin Biochem; 1989 May; 27(5):277-85. PubMed ID: 2760564 [TBL] [Abstract][Full Text] [Related]
15. Carboxypeptidases N (kininases I) in rat serum, lungs, liver and spleen and the inactivation of kinins (bradykinin). Petàkovà M; Simonianovà E; Rybàk M Physiol Bohemoslov; 1972 May; 21(3):287-93. PubMed ID: 4270022 [No Abstract] [Full Text] [Related]
16. C4a: the third anaphylatoxin of the human complement system. Gorski JP; Hugli TE; Müller-Eberhard HJ Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947 [TBL] [Abstract][Full Text] [Related]
17. Cellulose acetate beads activate the complement system but inactivate the anaphylatoxins generated. Takeda Y; Ohba M; Ueno M; Saniabadi AR; Wakabayashi I Artif Organs; 2010 Dec; 34(12):1144-9. PubMed ID: 20618220 [TBL] [Abstract][Full Text] [Related]
18. Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins. Tan F; Jackman H; Skidgel RA; Zsigmond EK; Erdös EG Anesthesiology; 1989 Feb; 70(2):267-75. PubMed ID: 2913861 [TBL] [Abstract][Full Text] [Related]
19. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. Cochrane CG; Müller-Eberhard HJ J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923 [TBL] [Abstract][Full Text] [Related]
20. A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation. Willemse JL; Hendriks DF Clin Chim Acta; 2006 Sep; 371(1-2):124-9. PubMed ID: 16616057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]